MetaCap

Arcturus Therapeutics (ARCT) News

NASDAQ: ARCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.45-0.15 (-1.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ARCT news summary

We found 5 recent headlines mentioning Arcturus Therapeutics (ARCT): 1 in the past week and 5 in the past 30 days, most often from Nasdaq, Business Wire. For price context, ARCT is down 1.97% at $7.45. The most recent story, "Arcturus Therapeutics Holdings Inc. Sells 2,466,395 Shares of Common Stock to Meiji Seika Pharma Co., Ltd. for $50.0 million", was published by Nasdaq on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Arcturus Therapeutics headlines

Stocks mentioned alongside ARCT

Compare ARCT